EFFICACY AND SAFETY OF INTRAVENOUS GOLIMUMAB IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM A PHASE 3 OPEN-LABEL STUDY

被引:0
|
作者
Spindler, Alberto [1 ]
Ruperto, Nicola [2 ]
Pacheco Tena, Cesar Francisco [3 ]
Louw, Ingrid [4 ]
Vega-Cornejo, Gabriel [5 ]
Kingsbury, Daniel [6 ]
Clark, Michael [7 ]
Bensley, Karen [7 ]
Li, Xiaoming [7 ]
Brunner, Hermine [8 ]
机构
[1] Ctr Med Privado Reumatol, San Miguel De Tucuman, Tucuman, Argentina
[2] Ist Giannina Gaslini, Pediat II, Reumatol, PRINTO Coordinating Ctr, Genoa, Italy
[3] Univ Autonoma Chihuahua, Circuito Univ Campus 2, Chihuahua, Mexico
[4] Panorama Med Ctr, Cape Town, South Africa
[5] Hosp Mexico Amer, Guadalajara, Jalisco, Mexico
[6] Legacy Emanuel, Randall Childrens Hosp, Portland, OR USA
[7] Janssen Res & Dev LLC, Spring House, PA USA
[8] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
323
引用
收藏
页码:S11 / S11
页数:1
相关论文
共 50 条
  • [1] EFFICACY AND SAFETY OF INTRAVENOUS GOLIMUMAB IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM A PHASE 3 OPEN-LABEL STUDY
    Ruperto, Nicolino
    Spindler, Alberto
    Pacheco Tena, Cesar Francisco
    Louw, Ingrid
    Vega Cornejo, Gabriel
    Kingsbury, Daniel
    Clark, Michael
    Bensley, Karen
    Li Xiaoming
    Brunner, Hermine
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 966 - 966
  • [2] Open-label phase 3 study of intravenous golimumab in patients with polyarticular juvenile idiopathic arthritis
    Ruperto, Nicolino
    Brunner, Hermine, I
    Pacheco-Tena, Cesar
    Louw, Ingrid
    Vega-Cornejo, Gabriel
    Spindler, Alberto J.
    Kingsbury, Daniel J.
    Schmeling, Heinrike
    Borzutzky, Arturo
    Cuttica, Ruben
    Inman, C. J.
    Malievskiy, Victor
    Scott, Christiaan
    Keltsev, Vladimir
    Terreri, Maria Teresa
    Viola, Diego Oscar
    Xavier, Ricardo M.
    Fernandes, Taciana A. Pedrosa
    Velazquez, Maria Del Rocio Maldonado
    Henrickson, Michael
    Clark, Michael B.
    Bensley, Karen A.
    Li, Xiaoming
    Lo, Kim Hung
    Leu, Jocelyn H.
    Hsu, Chyi-Hung
    Hsia, Elizabeth C.
    Xu, Zhenhua
    Martini, Alberto
    Lovell, Daniel J.
    [J]. RHEUMATOLOGY, 2021, 60 (10) : 4495 - 4507
  • [3] Open-label Phase 3 Study of Intravenous Golimumab in Patients with Polyarticular Juvenile Idiopathic Arthritis: Pharmacokinetics, Effectiveness, Safety, and Immunogenicity over 252 Weeks
    Ruperto, Nicolino
    Lovell, Daniel J.
    Ringold, Sarah
    Xu, Xie L.
    Leu, Jocelyn H.
    Lam, Edwin
    Wang, Yuhua
    Martini, Alberto
    Brunner, Hermine
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 695 - 696
  • [4] Efficacy and safety of canakinumab in systemic juvenile idiopathic arthritis: 48-week results from an open-label phase III study in Japanese patients
    Nishimura, Kenichi
    Hara, Ryoki
    Umebayashi, Hiroaki
    Takei, Syuji
    Iwata, Naomi
    Imagawa, Tomoyuki
    Shimizu, Masaki
    Tomiita, Minako
    Seko, Noriko
    Kitawaki, Tetsuji
    Yokota, Shumpei
    [J]. MODERN RHEUMATOLOGY, 2021, 31 (01) : 226 - 234
  • [5] Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study
    Ryoki Hara
    Hiroaki Umebayashi
    Syuji Takei
    Nami Okamoto
    Naomi Iwata
    Yuichi Yamasaki
    Yasuo Nakagishi
    Toshitaka Kizawa
    Ichiro Kobayashi
    Tomoyuki Imagawa
    Noriko Kinjo
    Norihito Amano
    Yoko Takahashi
    Masaaki Mori
    Yasuhiko Itoh
    Shumpei Yokota
    [J]. Pediatric Rheumatology, 17
  • [6] Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study
    Hara, Ryoki
    Umebayashi, Hiroaki
    Takei, Syuji
    Okamoto, Nami
    Iwata, Naomi
    Yamasaki, Yuichi
    Nakagishi, Yasuo
    Kizawa, Toshitaka
    Kobayashi, Ichiro
    Imagawa, Tomoyuki
    Kinjo, Noriko
    Amano, Norihito
    Takahashi, Yoko
    Mori, Masaaki
    Itoh, Yasuhiko
    Yokota, Shumpei
    [J]. PEDIATRIC RHEUMATOLOGY, 2019, 17 (1)
  • [7] Efficacy and Safety of Canakinumab in Patients with Systemic Juvenile Idiopathic Arthritis: Results from an Open-Label Long-Term Followup Study
    Brunner, Hermine L.
    Ruperto, Nicolino
    Quartier, Pierre
    Constantin, Tamas
    Alexeeva, Ekaterina
    Schneider, Rayfel
    Kone-Paut, Isabelle
    Schikler, Kenneth
    Marzan, Katherine
    Wulffraat, Nico
    Padeh, Shai
    Chasnyk, Vyacheslav
    Wouters, Carine
    Kuemmerle-Deschner, Jasmin B.
    Kallinich, Tilmann
    Lauwerys, Bernard
    Haddad, Elie
    Nasonov, Evgeny L.
    Trachana, Maria
    Vougiouka, Olga
    Leon, Karolynn
    Speziale, Antonio
    Lheritier, Karine
    Vritzali, Eleni
    Lovell, Daniel J.
    Martini, Alberto
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [8] Long-term efficacy and safety of canakinumab in the treatment of systemic juvenile idiopathic arthritis in Japanese patients: Results from an open-label Phase III study
    Iwata, Naomi
    Nishimura, Kenichi
    Hara, Ryoki
    Imagawa, Tomoyuki
    Shimizu, Masaki
    Tomiita, Minako
    Umebayashi, Hiroaki
    Takei, Syuji
    Seko, Noriko
    Wakabayashi, Ryota
    Yokota, Shumpei
    [J]. MODERN RHEUMATOLOGY, 2023, 33 (06) : 1162 - 1170
  • [9] Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension study
    Brunner, Hermine, I
    Akikusa, Jonathan D.
    Al-Abadi, Eslam
    Bohnsack, John F.
    Boteanu, Alina Lucica
    Chedeville, Gaelle
    Cuttica, Ruben
    De La Pena, Wendy
    Jung, Lawrence
    Kasapcopur, Ozgur
    Kobusinska, Katarzyna
    Schulert, Grant S.
    Neiva, Claudia
    Rivas-Chacon, Rafael
    Rodriguez, Juan Cruz Rizo
    Vazquez-Del Mercado, Monica
    Wagner-Weiner, Linda
    Weiss, Jennifer E.
    Wouters, Carine
    Posner, Holly
    Wouters, Ann
    Chang, Cheng
    White, Claire
    Kanik, Keith
    Liu, Shixue
    Martini, Alberto
    Lovell, Daniel J.
    Ruperto, Nicolino
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2024,
  • [10] Efficacy and Safety of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis: Results From an Open-Label, Long-Term Follow-up Study
    Brunner, Hermine
    Ruperto, Nicolino
    Quartier, Pierre
    Constantin, Tamas
    Alexeeva, Ekaterina
    Schneider, Rayfel
    Kone-Paut, Isabelle
    Schikler, Kenneth N.
    Marzan, Katherine
    Wulffraat, Nico
    Padeh, Shai
    Chasnyk, Vyacheslav
    Wouters, Carine
    Kuemmerle-Deschner, Jasmin B.
    Kallinich, Tilmann
    Lauwerys, Bernard
    Haddad, Elie
    Nasonov, Evgeny L.
    Trachana, Maria
    Vougiouka, Olga
    Leon, Karolynn
    Speziale, Antonio
    Lheritier, Karine
    Vritzali, Eleni
    Martini, Alberto
    Lovell, Daniel
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69 : 7 - 8